Fast Five Quiz: Systemic Treatments for Plaque Psoriasis

Chris G. Adigun, MD


May 21, 2020

Most international guidelines suggest that combined topical/systemic therapy may be needed to achieve optimal response in patients with plaque psoriasis as opposed to systemic therapy alone. Studies have shown that significant, clinically meaningful improvement in plaque psoriasis can be achieved with combined systemic/topical therapy.

Biologic and immunomodulatory therapies can be considered for patients with active psoriatic arthritis, as well as for those with more severe or intractable disease.

Most available data do not support the avoidance of specific antihypertensive medications (beta-blockers, calcium-channel blockers, or others) in patients with psoriasis. It should be noted, however, that certain medications for psoriasis may trigger or worsen hypertension.

Learn more about systemic therapies for plaque psoriasis.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: